Erik Adolf von Willebrand

From WikiMD's WELLNESSPEDIA

Erik Adolf von Willebrand (1 February 1870 – 12 September 1949) was a Finnish internist and pediatrician, best known for his research into bleeding disorders. Von Willebrand's most notable work was the discovery of the blood disorder, von Willebrand Disease, which was named after him.

Early Life and Education[edit]

Erik Adolf von Willebrand was born on 1 February 1870 in Finland. He pursued his medical studies at the University of Helsinki, where he graduated in 1896.

Career[edit]

After his graduation, von Willebrand worked as a pediatrician and internist. He was particularly interested in hematology, the study of blood, its disorders, and their treatment. His research led him to discover a previously unknown bleeding disorder, which is now known as von Willebrand Disease.

Von Willebrand Disease[edit]

Von Willebrand Disease is a genetic disorder caused by missing or defective von Willebrand factor (VWF), a clotting protein. The disease is characterized by heavy or prolonged bleeding. Von Willebrand first described the disease in 1926, after observing a young girl from the Åland Islands who had symptoms of a bleeding disorder.

Legacy[edit]

Erik Adolf von Willebrand's discovery has had a significant impact on the field of hematology. His work has helped in the diagnosis and treatment of bleeding disorders, improving the quality of life for many patients.

See Also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.